Skip to main content
Triangle logo TriangleGet started

Stereotactic Radiosurgery (NCT05419076)

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain: a one-minute explainerNCT054190761 min

Stereotactic Radiosurgery trial for Lung Cancer (NCT05419076). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults with small-cell lung cancer and up to twenty brain metastases. Prior brain radiation, leptomeningeal disease, or inability to undergo contrast-enhanced MRI excludes entry.

The idea: stereotactic radiosurgery targets visible brain tumors using MRI and CT planning. Doctors select sixteen to thirty gray over one to five sessions; different lesions may receive different doses. An initial lumbar puncture is required. Later spinal-fluid samples are optional. Researchers assess survival at six months.

This phase 2 study plans 62 patients. Luke Pike leads at MSK, New York; seven US sites recruit.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.